Social Media Ideas for Mrk

Merck & Co., Inc. (MRK) Discusses Oncology Strategy and Program Update With Focus on Clinical Progress and Pipeline...

Merck & Co., Inc. (MRK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Merck: Navigating the Patent Cliff and Future Growth Prospects

Join us as we dissect Merck's stock potential and the challenges it faces with the impending patent cliff of Keytruda. Can this pharmaceutical giant maintain its edge in the market...

Merck Animal Health announces acquisition of TARGAN

Rahway-based Merck Animal Health, a division of Merck & Co., Inc., announced that it has signed a definitive agreement to acquire TARGAN, a privately held innovator in developi...

Merck KGaA (MKKGY) Presents at DbAccess European Champions Conference 2026 - Slideshow

Marksans Pharma acquires German OTC distributor ABCnow GmbH for €892,384

The acquisition gives Marksans direct front-end sales and distribution infrastructure in Germany, which will be used for marketing products manufactured across its India, UK, and U...

<![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]>

Merck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitis

Merck is making advances in the lucrative ulcerative colitis field with the key prize of its $11 billion buyout from several years ago.

Marks and Spencer Group plc (MAKSY) Q4 2026 Earnings Call Transcript

TARGAN announces sale to Merck Animal Health

Raleigh, North Carolina, United States, June 11, 2026 — TARGAN Inc, a privately held innovator in developing and commercializing biodevice solutions to improve performance outcomes...

Newmark: A Clear Opportunity Ahead Of Q2 Earnings

Marks and Spencer Group plc 2026 Q4 - Results - Earnings Call Presentation

Milestone

Milestone Anonymous (not verified) Mon, 05/18/2026 - 08:33 field_thread_url https://cafepharma.com/boards/threads/milestone.694258/ boar...

<![CDATA[Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Joh...

Merck KGaA: Bio-Techne Acquisition Improves Quality, But The Stock Seems Fully Valued (Downgrade)

Merck ADC, licensed from China, hits mark in first big global trial

The endometrial cancer trial is the first of 17 late-stage studies Merck is running for a therapy that’s important to its ambitions of hitting $70 billion in annual sales next deca...

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable

McCormick: Unilever Synergies Create A Great Long-Term Story

Merck launches GCC in Bengaluru

Merck’s Bengaluru GCC to bring together approximately 3,300 professionals

Market Update: MKTX, VMC

Marti Technologies, Inc. (MRT) Q1 2026 Earnings Call Transcript

<![CDATA[Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpha...

<![CDATA[Pharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmace...

Analyst Report: Markel Group Inc